AfoliOpen Afoli →

Bimatoprost

Bimatoprost is an approved active ingredient.

Open in Afoli Medicines →

Chemical compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

DURYSTA ® (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).

US label

Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).

EMA

How it works

Common side effects

The following clinically significant adverse reactions are described elsewhere in labeling: Implant migration Hypersensitivity Corneal adverse reactions Macular edema Intraocular inflammation Pigmentation Endophthalmitis In controlled studies, the most common ocular adverse reaction reported by 27% of patients was…

US label

Who should not take it

Ocular or periocular infections Corneal endothelial cell dystrophy Prior corneal transplantation Absent or ruptured posterior lens capsule Hypersensitivity 4.1 Ocular or Periocular Infections DURYSTA is contraindicated in patients with active or suspected…

US label

Pregnancy and breastfeeding

There are no adequate and well-controlled studies of DURYSTA (bimatoprost intracameral implant) administration in pregnant women to inform a drug associated risk.

Excerpts from the US prescribing label (public domain), copied without changes.

Brand names

United States

Durysta · Latisse · Lumigan · Zolymbus

European Union

Lumigan

Canada

Ag-Bimatoprost RC · Apo-Bimatoprost · Apo-Bimatoprost RC · Bimatoprost RC · Jamp Bimatoprost · Jamp Bimatoprost Solution RC · Latisse · Lumigan RC · Pro-Bimatoprost RC · Vistitan · Zimed PF · Zolymbus

Approval status

US Food and Drug Administration
prescription · since 2001
European Medicines Agency
authorised · since 2002
Health Canada
prescription · marketed
First approval anywhere
2001

Codes

ATC
S01EE03
RxNorm CUI
283810
ChEMBL
CHEMBL1200963
PubChem CID
5311027
UNII
QXS94885MZ
Wikidata
Q2393348

Frequently asked questions

What is Bimatoprost used for?

Bimatoprost is used for: Glaucoma, Hypotrichosis, Open-angle glaucoma, and Ocular hypertension.

What are the brand names of Bimatoprost?

Brand names of Bimatoprost include Durysta, Latisse, Lumigan, Zolymbus, Ag-Bimatoprost RC, Apo-Bimatoprost, Apo-Bimatoprost RC, and Bimatoprost RC.

Medicines in the same class

Sources and licences

Updated November 15, 2026